Compounding Pharmacy · Houston, TX · 503A
VialsRx Review
VialsRx is a 503A community sterile compounding pharmacy in Houston, Texas, licensed by the Texas State Board of Pharmacy (license #35264). It prepares compounded semaglutide and tirzepatide (GLP-1) per individual prescription under USP <797> sterile-compounding standards and ships to all 50 states. Note: routine 503A compounding of GLP-1s that copy commercially available products is restricted now that the FDA shortages are resolved.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
About this pharmacy
VialsRx is a 503A community sterile compounding pharmacy in Houston, Texas, licensed by the Texas State Board of Pharmacy (license #35264). It prepares compounded semaglutide and tirzepatide (GLP-1) per individual prescription under USP <797> sterile-compounding standards and ships to all 50 states. Note: routine 503A compounding of GLP-1s that copy commercially available products is restricted now that the FDA shortages are resolved.
Certifications & Compliance
All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.
We have not verified any third-party accreditations for this pharmacy beyond its state pharmacy license.
Drugs Produced
Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].
States Licensed (0)
Regulatory Actions
Weight Loss Rankings Score Breakdown
Scores are independently researched. See our methodology for details.
Medium confidence · Last verified 2026-06-04 via manual · How we verify provider data
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- 503B outsourcing facility · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources & methodology — as of June 2026
- 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
- 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
- 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
- 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.